Monashee Investment Management LLC purchased a new position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 74,792 shares of the biotechnology company’s stock, valued at approximately $1,426,000. A number of other institutional investors […]
Monashee Investment Management LLC bought a new position in shares of Runway Growth Finance Corp. (NASDAQ:RWAY – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 91,739 shares of the company’s stock, valued at approximately $1,158,000. A number of other institutional investors and hedge funds have also bought and sold shares of […]
Monashee Investment Management LLC bought a new position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 103,300 shares of the company’s stock, valued at approximately $522,000. Several other institutional investors also recently modified their holdings […]
Monashee Investment Management LLC purchased a new stake in bluebird bio, Inc. (NASDAQ:BLUE – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund purchased 500,000 shares of the biotechnology company’s stock, valued at approximately $690,000. Several other large investors have also added to or reduced their stakes in the business. Citigroup Inc. increased its […]
Shares of Transcat, Inc. (NASDAQ:TRNS – Get Free Report) have received an average rating of “Moderate Buy” from the four research firms that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month […]